Skip to main content

Clinical trial IJB_2719

A Phase 1/2, Open-Label, Dose-Escalation / Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies

Cancers
Organ solid tumors
Trial status Trial open for recruitment
Investigator
Trial type
Prospective interventional
Phase Trial phase 1/2
Academic trial Non
Sponsor Incyte Corporate
EudraCT Identifier 2017-001710-28
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02712905
Inclusion criteria Any line
Last update